Related Experiment Video
Updated: Dec 31, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Confounding biases in studies on early- versus late-caffeine in preterm infants: a systematic review
Sandra Nylander Vujovic1, Chiara Nava2, Minna Johansson3
1Skane University Hospital, Lund, Sweden.
Insights
Early caffeine administration in preterm infants may not reduce harm. Current evidence is insufficient to determine optimal timing, necessitating further research with long-term outcome focus.
Area of Science:
- Neonatal Medicine
- Pharmacology
Background:
- Caffeine is used for apnea of prematurity and extubation in preterm infants.
- Early caffeine initiation aims to reduce respiratory morbidity but may pose risks.
- The optimal timing for caffeine administration remains unclear.
Purpose of the Study:
- To systematically review evidence on whether early caffeine administration reduces morbidity and mortality in preterm infants.
- To assess the impact of timing on infant outcomes.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) and cohort studies.
- Literature search conducted in February 2019 without restrictions.
- Included studies compared early versus late caffeine administration in infants born before 34 weeks gestation.
Main Results:
- Included two RCTs and 14 cohort studies, most with high risk of bias.
- Limited data available on long-term or patient-relevant outcomes.
- No meta-analysis was possible due to study heterogeneity.
Conclusions:
- Current evidence is insufficient to determine the optimal timing of caffeine administration.
- Methodological limitations in cohort studies hinder definitive conclusions.
- Further high-quality RCTs focusing on patient-relevant and long-term outcomes are needed.
Background:
Caffeine is indicated for the management of apnoea of prematurity and extubation in preterm infants. Early initiation of caffeine administration has increased in the past decades with the purpose of reducing respiratory morbidity. However, there might be harms associated with this approach. This systematic review aims to assess whether early administration of caffeine reduces morbidity and mortality in preterm infants.
Methods:
The methods were published in a preregistered protocol. The literature search was performed in February 2019 with no restrictions for language or publication date. Randomised controlled trials (RCTs) and cohort studies comparing early versus late caffeine administration to infants born before week 34 were included.
Results:
Two RCTs and 14 cohort studies were included. All studies but one had a serious/critical overall risk of bias. Few studies reported on long-term or patient-relevant outcomes. No meta-analysis could be performed.
Conclusion:
Based on the available evidence, no conclusions about the optimal timing of caffeine administration can be drawn. There are inherent methodological problems in the cohort studies. RCTs are needed to answer the question of optimal timing for caffeine administration in neonatal care. Future trials should focus on outcomes relevant to patients and their families and include long-term outcomes.
Related Concept Videos
Experimental Designs
Blind Procedures
Bias in Epidemiological Studies
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Factors Affecting Drug Response: Overview
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...

